Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Publication year range
1.
Balkan Med J ; 35(2): 191-195, 2018 03 15.
Article in English | MEDLINE | ID: mdl-29188783

ABSTRACT

AIMS: To investigate the epidemiology of Clostridium difficile infection in Romanian hospitals. METHODS: A survey was conducted at nine hospitals throughout Romania between November 2013 and February 2014. RESULTS: The survey identified 393 patients with Clostridium difficile infection. The median age was 67 years (range: 2-94 years); 56% of patients were aged >65 years. The mean prevalence of Clostridium difficile infection was 5.2 cases per 10.000 patient-days. The highest prevalences were 24.9 and 20 per 10.000 patient-days in hospitals specializing in gastroenterology and infectious diseases, respectively. Clostridium difficile infections were health care-associated in 70.5% patients and community-acquired in 10.2%. The origin was not determined in 19.3%. Clostridium difficile infection was severe in 12.3% of patients, and the in-hospital all-cause mortality was 8.8%. Polymerase chain reaction ribotype 027 had the highest prevalence in all participating hospitals and represented 82.6% of the total ribotyped isolates. The minimum inhibitory concentration of moxifloxacin was >4 µg/mL for 59 of 80 tested isolates (73.8%). Of 59 isolates, 54 were highly resistant to moxifloxacin (minimum inhibitory concentration ≥32 µg/mL), and the majority were polymerase chain reaction ribotype 027 (p<0.0001). CONCLUSION: The ribotype 027 was the predominant cause of Clostridium difficile infections in Romania. In some specialized hospitals, the prevalence of Clostridium difficile infection was higher than the European mean prevalence, and this demonstrates the need for strict adherence to infection control programs.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Polymerase Chain Reaction/methods , Ribotyping , Clostridioides difficile/genetics , Cross Infection/epidemiology , Humans , Prevalence , Romania/epidemiology
2.
Article in Romanian | MEDLINE | ID: mdl-21553478

ABSTRACT

C. difficile is recognised as the main cause for colitis in hospitalised patients which are treated with antibiotics, chemotherapics or other drugs that disturb intestinal microbiota. Thus, a rapid and correct diagnostic of Clostridium difficile infections is essential for preventing nosocomial infection spread. Empiric therapy, regardless of the laboratory investigation results, is inadequate, especially in epidemic situations, as not all the cases of diarrhoea are due to C. difficile infection. Other risk factors for CDAD (Clostridiumn difficile Associated Diseases might be: prolonged hospitalization or residency in an asylum, age, existence of a severe chronic disease in the background nasogastric intubation, anti-ulcer drugs, at less extent gastrointestinal surgery, other immunosuppresive compounds etc. In our country, C. difficile infection is rather frequent in adults, though it is not always reported by clinicians. The circulation of endemic rybotype 027 in Romania is not well documented, the rybotype being extremely virulent and spread in other European countries. Hence the importance of extending the diagnostic capacity of C. difficile infection in order to allow detection of this rybotype among the strains isolated in our country.


Subject(s)
Anti-Bacterial Agents/adverse effects , Clostridioides difficile/isolation & purification , Clostridium Infections/microbiology , Cross Infection/microbiology , Diarrhea/microbiology , Anti-Bacterial Agents/administration & dosage , Clostridium Infections/diagnosis , Clostridium Infections/epidemiology , Clostridium Infections/prevention & control , Cross Infection/diagnosis , Cross Infection/epidemiology , Cross Infection/prevention & control , Diarrhea/diagnosis , Diarrhea/epidemiology , Diarrhea/prevention & control , Global Health , Humans , Incidence , Ribotyping , Risk Factors , Romania/epidemiology
3.
Roum Arch Microbiol Immunol ; 64(1-4): 11-6, 2005.
Article in English | MEDLINE | ID: mdl-17405309

ABSTRACT

The aim of this study was to evaluate the immunomodulatory effect of the staphylococcal vaccine inoculated subcutaneously in 15 patients with chronic periodontitis. Bacteriological investigation of samples collected from the periodontal pocket for aerobic and anaerobic microorganisms was performed by classic bacteriological procedures before and after vaccination. The following immune system parameters were evaluated: C reactive protein (CRP), serum level of C3 complement fraction, IgG, IgA, and IgM by immunodiffusion, PMN granulocytes ROS release after in vitro stimulation with opsonized zymosan (OZ) and Concanavalin A (ConA) by chemiluminescence assay and lymphocytes sets and subsets by flow-cytometry immunophenotyping. The microbiological investigations revealed high frequency of Staphylococcus spp isolation and the presence of the most common anaerobe agents incriminated in human periodontitis like Fusobacterium, Porphyromonas, Peptostreptococcus, Veillonella spp and the reduction of this flora in the periodontal pocket after therapy. The immunological parameters quantification showed the absence of CRP, normal values of C3, IgG, IgA, IgM in the majority of cases. All patients presented normal values of lymphocytes sets and subsets. Significant increase of PMN respiratory burst after ConA stimulation was observed before vaccination which turned to normal values after therapy and a low ROS level both before and after therapy suggesting PMN Fc receptors dysfunction in this group of patients. The data presented in our study suggest an immunomodulatory effect of staphylococcal vaccine therapy in periodontitis and high frequency of Staphylococcus spp recovering from the periodontal pocket of investigated subjects.


Subject(s)
Periodontal Pocket/therapy , Staphylococcal Vaccines/therapeutic use , Vaccination , Adult , Aged , Antibody Formation , Bacteria, Anaerobic/isolation & purification , Chronic Disease , Female , Humans , Immunity, Cellular , Injections, Subcutaneous , Male , Middle Aged , Periodontal Pocket/immunology , Periodontal Pocket/microbiology , Staphylococcal Vaccines/administration & dosage , Staphylococcus/isolation & purification , Staphylococcus aureus/immunology
SELECTION OF CITATIONS
SEARCH DETAIL